Pharmacokinetic Interaction Study of Steady-state Tipranavir/Ritonavir (TPV/r) With Single-dose Valaciclovir (VAL) in Healthy Volunteers

NCT02226978 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Tipranavir
DRUG: Ritonavir
DRUG: Valaciclovir

Sponsor

Boehringer Ingelheim